Citigroup Lowers their Rating for Shares of MedEquities Realty Trust (MRT). Are Other Analysts Next?

September 15, 2018 - By James Guidry

MedEquities Realty Trust (MRT) Receives a Downgrade

Research professionals at Citigroup’s equities division downgraded shares of MedEquities Realty Trust (MRT) from a “Neutral” to a “Sell” rating today. Theses analysts currently have a PT of $9 on MRT equating to a -6.83 % downside.

MedEquities Realty Trust, Inc. (NYSE:MRT) Ratings Coverage

Among 4 analysts covering MedEquities Realty Trust (MRT), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. MedEquities Realty Trust has $13 highest and $11 lowest target. $12.20’s average target is 26.29% above currents $9.66 stock price. MedEquities Realty Trust had 6 analyst reports since April 16, 2018 according to SRatingsIntel. The firm has “Sector Perform” rating given on Wednesday, May 23 by RBC Capital Markets. The rating was maintained by KeyBanc Capital Markets on Monday, April 16 with “Buy”. The rating was maintained by Canaccord Genuity on Thursday, August 9 with “Overweight”. The rating was downgraded by KeyBanc Capital Markets to “Sector Weight” on Wednesday, August 8.

The stock decreased 4.45% or $0.45 during the last trading session, reaching $9.66. About 475,063 shares traded or 244.62% up from the average. MedEquities Realty Trust, Inc. (MRT) has declined 11.96% since September 15, 2017 and is downtrending. It has underperformed by 27.58% the S&P500.

Analysts await MedEquities Realty Trust, Inc. (NYSE:MRT) to report earnings on November, 6. They expect $0.30 EPS, up 3.45 % or $0.01 from last year’s $0.29 per share. MRT’s profit will be $9.56M for 8.05 P/E if the $0.30 EPS becomes a reality. After $0.30 actual EPS reported by MedEquities Realty Trust, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

MedEquities Realty Trust is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The company has market cap of $307.79 million. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. It has a 15.84 P/E ratio. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.

Another recent and important MedEquities Realty Trust, Inc. (NYSE:MRT) news was published by which published an article titled: “Benzinga’s Top Upgrades, Downgrades For September 14, 2018” on September 14, 2018.

MedEquities Realty Trust, Inc. (NYSE:MRT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: